TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2017 DA - 2017// TI - Cancer statistics, 2017 JO - CA Cancer J Clin VL - 67 UR - https://doi.org/10.3322/caac.21387 DO - 10.3322/caac.21387 ID - Siegel2017 ER - TY - JOUR AU - Cheng, J. X. AU - Zhang, X. AU - Liu, B. L. PY - 2009 DA - 2009// TI - Health-related quality of life in patients with high-grade glioma JO - Neuro-Oncology VL - 11 UR - https://doi.org/10.1215/15228517-2008-050 DO - 10.1215/15228517-2008-050 ID - Cheng2009 ER - TY - JOUR AU - Scott, J. N. AU - Brasher, P. M. A. AU - Sevick, R. J. AU - Rewcastle, N. B. AU - Forsyth, P. A. PY - 2002 DA - 2002// TI - How often are nonenhancing supratentorial gliomas malignant? A population study JO - Neurology VL - 59 UR - https://doi.org/10.1212/WNL.59.6.947 DO - 10.1212/WNL.59.6.947 ID - Scott2002 ER - TY - STD TI - Approvals SODDa. U.S. Food & Drug Administration website. https://www.accessdata.fda.gov/scripts/opdlisting/oopd/index.cfm. Accessed 30 May 2017. UR - https://www.accessdata.fda.gov/scripts/opdlisting/oopd/index.cfm ID - ref4 ER - TY - STD TI - Sasajima T, Ono T, Shimada N, Doi Y, Oka S, Kanagawa M, et al. Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas. Nucl Med Biol. 2013;40:808–15. https://doi.org/10.1016/j.nucmedbio.2013.04.007. ID - ref5 ER - TY - STD TI - Doi Y, Kanagawa M, Maya Y, Tanaka A, Oka S, Nakata N, et al. Evaluation of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid accumulation in low-grade glioma in chemically induced rat models: PET and autoradiography compared with morphological images and histopathological findings. Nucl Med Biol. 2015;42:664–72. https://doi.org/10.1016/j.nucmedbio.2015.04.008. ID - ref6 ER - TY - STD TI - Kondo A, Ishii H, Aoki S, Suzuki M, Nagasawa H, Kubota K, et al. Phase IIa clinical study of [18F]fluciclovine: efficacy and safety of a new PET tracer for brain tumors. Ann Nucl Med. 2016;30:608–18. https://doi.org/10.1007/s12149-016-1102-y. ID - ref7 ER - TY - STD TI - Shoup TM, Olson J, Hoffman JM, Votaw J, Eshima D, Eshima L, et al. Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors. J Nucl Med. 1999;40:331–8. ID - ref8 ER - TY - STD TI - Wakabayashi T, Iuchi T, Tsuyuguchi N, Nishikawa R, Arakawa Y, Sasayama T, et al. Diagnostic performance and safety of positron emission tomography using (18)F-fluciclovine in patients with clinically suspected high- or low-grade gliomas: a multicenter phase IIb trial. Asia Ocean J Nucl Med Biol. 2017;5:10–21. https://doi.org/10.22038/aojnmb.2016.7869. ID - ref9 ER - TY - STD TI - Tsuyuguchi N, Terakawa Y, Uda T, Nakajo K, Kanemura Y. Diagnosis of brain tumors using amino acid transport PET imaging with (18)F-fluciclovine: a comparative study with L-methyl-(11)C-methionine PET imaging. Asia Ocean J Nucl Med Biol. 2017;5:85–94. https://doi.org/10.22038/aojnmb.2017.8843.. ID - ref10 ER - TY - STD TI - Ono M, Oka S, Okudaira H, Schuster DM, Goodman MM, Kawai K, et al. Comparative evaluation of transport mechanisms of trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid and L-[methyl-(11)C]methionine in human glioma cell lines. Brain Res. 2013;1535:24–37. https://doi.org/10.1016/j.brainres.2013.08.037. ID - ref11 ER - TY - STD TI - Oka S, Okudaira H, Yoshida Y, Schuster DM, Goodman MM, Shirakami Y. Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cells. Nucl Med Biol. 2012;39:109–19. https://doi.org/10.1016/j.nucmedbio.2011.06.008. ID - ref12 ER - TY - JOUR AU - Smith, Q. R. PY - 2000 DA - 2000// TI - Transport of glutamate and other amino acids at the blood-brain barrier JO - J Nutr VL - 130 UR - https://doi.org/10.1093/jn/130.4.1016S DO - 10.1093/jn/130.4.1016S ID - Smith2000 ER - TY - STD TI - McConathy J, Voll RJ, Yu W, Crowe RJ, Goodman MM. Improved synthesis of anti-[18F]FACBC: improved preparation of labeling precursor and automated radiosynthesis. Appl Radiat Isot. 2003;58:657–66. ID - ref14 ER - TY - JOUR AU - van Velden, F. H. AU - Kloet, R. W. AU - van Berckel, B. N. AU - Wolfensberger, S. P. AU - Lammertsma, A. A. AU - Boellaard, R. PY - 2008 DA - 2008// TI - Comparison of 3D-OP-OSEM and 3D-FBP reconstruction algorithms for High-Resolution Research Tomograph studies: effects of randoms estimation methods JO - Phys Med Biol VL - 53 UR - https://doi.org/10.1088/0031-9155/53/12/010 DO - 10.1088/0031-9155/53/12/010 ID - van Velden2008 ER - TY - STD TI - Tscherpel C, Dunkl V, Ceccon G, Stoffels G, Judov N, Rapp M, et al. The use of O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of gliomas located in the brainstem and spinal cord. Neuro-Oncology. 2016; https://doi.org/10.1093/neuonc/now243. ID - ref16 ER - TY - STD TI - Schwarzenberg J, Czernin J, Cloughesy TF, Ellingson BM, Pope WB, Grogan T, et al. Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy. Clin Cancer Res. 2014;20:3550–9. https://doi.org/10.1158/1078-0432.CCR-13-1440. ID - ref17 ER - TY - STD TI - Nedergaard MK, Kristoffersen K, Michaelsen SR, Madsen J, Poulsen HS, Stockhausen MT, et al. The use of longitudinal 18F-FET MicroPET imaging to evaluate response to irinotecan in orthotopic human glioblastoma multiforme xenografts. PLoS One. 2014;9:e100009. https://doi.org/10.1371/journal.pone.0100009. ID - ref18 ER - TY - JOUR AU - Johannessen, A. L. AU - Torp, S. H. PY - 2006 DA - 2006// TI - The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas JO - Pathol Oncol Res VL - 12 UR - https://doi.org/10.1007/BF02893360 DO - 10.1007/BF02893360 ID - Johannessen2006 ER - TY - JOUR AU - Turkalp, Z. AU - Karamchandani, J. AU - Das, S. PY - 2014 DA - 2014// TI - IDH mutation in glioma: new insights and promises for the future JO - JAMA Neurol VL - 71 UR - https://doi.org/10.1001/jamaneurol.2014.1205 DO - 10.1001/jamaneurol.2014.1205 ID - Turkalp2014 ER - TY - JOUR AU - Law, M. AU - Yang, S. AU - Wang, H. AU - Babb, J. S. AU - Johnson, G. AU - Cha, S. PY - 2003 DA - 2003// TI - Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging JO - AJNR Am J Neuroradiol VL - 24 ID - Law2003 ER - TY - JOUR AU - Yanagida, O. AU - Kanai, Y. AU - Chairoungdua, A. AU - Kim, D. K. AU - Segawa, H. AU - Nii, T. PY - 2001 DA - 2001// TI - Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines JO - Biochim Biophys Acta VL - 1514 UR - https://doi.org/10.1016/S0005-2736(01)00384-4 DO - 10.1016/S0005-2736(01)00384-4 ID - Yanagida2001 ER - TY - JOUR AU - Imai, H. AU - Kaira, K. AU - Oriuchi, N. AU - Shimizu, K. AU - Tominaga, H. AU - Yanagitani, N. PY - 2010 DA - 2010// TI - Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer JO - Anticancer Res VL - 30 ID - Imai2010 ER - TY - JOUR AU - del Amo, E. M. AU - Urtti, A. AU - Yliperttula, M. PY - 2008 DA - 2008// TI - Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2 JO - Eur J Pharm Sci VL - 35 UR - https://doi.org/10.1016/j.ejps.2008.06.015 DO - 10.1016/j.ejps.2008.06.015 ID - del Amo2008 ER - TY - STD TI - Heiss P, Mayer S, Herz M, Wester HJ, Schwaiger M, Senekowitsch-Schmidtke R. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med. 1999;40:1367–73. ID - ref25 ER - TY - STD TI - Youland RS, Kitange GJ, Peterson TE, Pafundi DH, Ramiscal JA, Pokorny JL, et al. The role of LAT1 in (18)F-DOPA uptake in malignant gliomas. J Neuro-Oncol. 2013;111:11–8. https://doi.org/10.1007/s11060-012-0986-1. ID - ref26 ER - TY - JOUR AU - Jansen, N. L. AU - Graute, V. AU - Armbruster, L. AU - Suchorska, B. AU - Lutz, J. AU - Eigenbrod, S. PY - 2012 DA - 2012// TI - MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET? JO - Eur J Nucl Med Mol Imaging VL - 39 UR - https://doi.org/10.1007/s00259-012-2109-9 DO - 10.1007/s00259-012-2109-9 ID - Jansen2012 ER - TY - JOUR AU - Popperl, G. AU - Kreth, F. W. AU - Mehrkens, J. H. AU - Herms, J. AU - Seelos, K. AU - Koch, W. PY - 2007 DA - 2007// TI - FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading JO - Eur J Nucl Med Mol Imaging VL - 34 UR - https://doi.org/10.1007/s00259-007-0534-y DO - 10.1007/s00259-007-0534-y ID - Popperl2007 ER - TY - JOUR AU - Langen, K. J. AU - Bartenstein, P. AU - Boecker, H. AU - Brust, P. AU - Coenen, H. H. AU - Drzezga, A. PY - 2011 DA - 2011// TI - German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids JO - Nuklearmedizin VL - 50 UR - https://doi.org/10.3413/nuk-2011041 DO - 10.3413/nuk-2011041 ID - Langen2011 ER - TY - STD TI - Albert NL, Winkelmann I, Suchorska B, Wenter V, Schmid-Tannwald C, Mille E, et al. Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20–40 min scans. Eur J Nucl Med Mol Imaging. 2016;43:1105–14. https://doi.org/10.1007/s00259-015-3276-2. ID - ref30 ER - TY - STD TI - Fueger BJ, Czernin J, Cloughesy T, Silverman DH, Geist CL, Walter MA, et al. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas. J Nucl Med. 2010;51:1532–8. https://doi.org/10.2967/jnumed.110.078592. ID - ref31 ER - TY - JOUR AU - Manabe, O. AU - Hattori, N. AU - Yamaguchi, S. AU - Hirata, K. AU - Kobayashi, K. AU - Terasaka, S. PY - 2015 DA - 2015// TI - Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-015-2996-7 DO - 10.1007/s00259-015-2996-7 ID - Manabe2015 ER - TY - STD TI - Kratochwil C, Combs SE, Leotta K, Afshar-Oromieh A, Rieken S, Debus J, et al. Intra-individual comparison of (18)F-FET and (18)F-DOPA in PET imaging of recurrent brain tumors. Neuro-Oncology. 2014;16:434–40. https://doi.org/10.1093/neuonc/not199. ID - ref33 ER - TY - STD TI - Oka S, Okudaira H, Ono M, Schuster DM, Goodman MM, Kawai K, et al. Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose. Mol Imaging Biol. 2014;16:322–9. https://doi.org/10.1007/s11307-013-0693-0. ID - ref34 ER -